Biofrontera Inc (BFRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,176 | -9,527 | -4,203 | -17,759 | -16,363 |
| Depreciation Amortization | 648 | 441 | 219 | 1,149 | 928 |
| Accounts receivable | 2,365 | 1,418 | 1,330 | -315 | 177 |
| Accounts payable and accrued liabilities | 1,782 | 2,412 | 1,444 | -1,452 | -1,281 |
| Other Working Capital | 3,974 | 2,019 | 103 | 6,212 | 6,104 |
| Other Operating Activity | -3,578 | -3,925 | -3,010 | 1,895 | 1,182 |
| Operating Cash Flow | $-10,985 | $-7,162 | $-4,117 | $-10,270 | $-9,253 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 57 | 57 |
| PPE Investments | -3 | -4 | -3 | -10 | -9 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -50 | -50 |
| Other Investing Activity | 0 | 0 | 0 | -50 | -50 |
| Investing Cash Flow | $-3 | $-4 | $-3 | $-3 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 4,050 | N/A |
| Common Stock Issued | N/A | 8,500 | N/A | N/A | N/A |
| Other Financing Activity | 8,500 | 0 | 0 | 10,785 | 10,785 |
| Financing Cash Flow | $8,500 | $8,500 | $N/A | $14,835 | $10,785 |
| Beginning Cash Position | 6,105 | 6,105 | 6,105 | 1,543 | 1,543 |
| End Cash Position | 3,617 | 7,439 | 1,985 | 6,105 | 3,073 |
| Net Cash Flow | $-2,488 | $1,334 | $-4,120 | $4,562 | $1,530 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,985 | -7,162 | -4,117 | -10,270 | -9,253 |
| Capital Expenditure | -3 | -4 | -3 | -10 | -9 |
| Free Cash Flow | -10,988 | -7,166 | -4,120 | -10,280 | -9,262 |